Literature DB >> 12135063

Sildenafil (viagra) is a risk factor for acute variceal bleeding.

Charalabos Tzathas, Ageliki Christidou, Spiros D Ladas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12135063     DOI： 10.1111/j.1572-0241.2002.05876.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  10 in total

1.  Epistaxis after sildenafil.

Authors:  Simon R J Bott; Iqbal Shergill; Manit Arya
Journal:  J R Soc Med       Date:  2002-10       Impact factor: 5.344

Review 2.  Treatment Barriers in Portopulmonary Hypertension.

Authors:  Batool AbuHalimeh; Michael J Krowka; Adriano R Tonelli
Journal:  Hepatology       Date:  2018-12-18       Impact factor: 17.425

3.  Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.

Authors:  Christian M Kähler; Ivo Graziadei; Helene Vogelsinger; Susanna Desole; Katharina Cima; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2011-03-31       Impact factor: 1.704

Review 4.  Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.

Authors:  Carmina Montoliu; Regina Rodrigo; Pilar Monfort; Marta Llansola; Omar Cauli; Jordi Boix; Nisrin Elmlili; Ana Agusti; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2010-03-02       Impact factor: 3.584

5.  Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.

Authors:  Ying-Wen Wang; Han-Chieh Lin; Ying-Ying Yang; Ming-Chih Hou; Shou-Dong Lee
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

Review 6.  Safety of sildenafil in infants*.

Authors:  Samira Samiee-Zafarghandy; P Brian Smith; Johannes N van den Anker
Journal:  Pediatr Crit Care Med       Date:  2014-05       Impact factor: 3.624

7.  Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis.

Authors:  Jens-Otto Clemmesen; Annamaria Giraldi; Peter Ott; Kim Dalhoff; Bent-Adel Hansen; Fin-Stolze Larsen
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

8.  Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver.

Authors:  Leonie Halverscheid; Peter Deibert; René Schmidt; Hubert E Blum; Torsten Dunkern; Benedikt H J Pannen; Wolfgang Kreisel
Journal:  BMC Gastroenterol       Date:  2009-09-18       Impact factor: 3.067

9.  Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications.

Authors:  Regina Rodrigo; Pilar Monfort; Omar Cauli; Slaven Erceg; Vicente Felipo
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

10.  Phosphodiesterase 5 inhibitors lower both portal and pulmonary pressure in portopulmonary hypertension: a case report.

Authors:  Hinrich C Bremer; Wolfgang Kreisel; Kai Roecker; Michael Dreher; Daniel Koenig; Anna Katharina Kurz-Schmieg; Hubert E Blum; Martin Roessle; Peter Deibert
Journal:  J Med Case Rep       Date:  2007-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.